Back

ARMR-100 generates anti-fentanyl immune response in human trial

Verifying
  • ARMR Sciences reported an anti-fentanyl immune response from its ARMR-100 human clinical trial.
  • Four patient cohorts were dosed, with no vaccine-related serious adverse events reported.
  • ARMR received a Department of War contract and FDA MIDD program acceptance.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.